申请人:Shiga University Of Medical Science
公开号:EP2944626A1
公开(公告)日:2015-11-18
Disclosed is a compound represented by formula (1) or a salt thereof, formula (1) :
wherein X is a residue of a compound having activity of binding to at least one member selected from the group consisting of amyloid β proteins, tau proteins, α-synuclein, and TDP-43; m is an integer of 0 to 6; n is an integer of 1 to 5; and J is a group selected from the group consisting of
wherein R1 and R2 are each independently a hydrogen atom, a fluorine atom, methyl, or trifluoromethyl; R3 is trifluoromethyl or trifluoromethoxy; and p is an integer of 1 to 4, provided that m + n ≥ 5 when J is J-1, and m + n ≥ 7 when J is J-2 or J-3.
公开了一种由式(1)代表的化合物或其盐,式(1) :
其中 X 是具有与至少一种选自淀粉样β蛋白、tau 蛋白、α-突触核蛋白和 TDP-43 组成的组的成员结合的活性的化合物的残基;m 是 0 至 6 的整数;n 是 1 至 5 的整数;以及 J 是选自以下组成的组的基团
其中 R1 和 R2 各自独立地为氢原子、氟原子、甲基或三氟甲基;R3 为三氟甲基或三氟甲氧基;以及 p 为 1 至 4 的整数,条件是当 J 为 J-1 时 m + n ≥ 5,而当 J 为 J-2 或 J-3 时 m + n ≥ 7。